Incyte | INCY - 市值



金融业
股票价格
USD
资产
USD 7.87B
现金及等价物
USD 3.98B
销售成本
USD 104.96M
流动资产
USD 6.03B
流动负债
USD 1.31B
债务
USD 38.27M
EBIT
USD 700.4M
EBITDA
USD 778.57M
员工
2.62K
EPS每股收益
USD 3.09
股本和储备
USD 6.34B
销售毛利
USD 1.57B
债务利息支出
USD 582K
利息收入
USD 38.12M
贷款资金
USD 28.42M
市值
USD 28.6B
净收入
USD 585.61M
营业费用
USD 973.64M
营业利润
USD 700.4M
普通股股本
USD 200.98M
PE价格收益
14.45
税前利润
USD 751.51M
销售收入
USD 1.67B
销售和管理费用
USD 351.74M
股票
USD 112.54M
贸易债权人
USD 1.39B
应收帐款人
USD 1.13B


市值 更改 日
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Agenus USD 128M 21M 2026-03
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Exelixis USD 13.54B 2.65B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MacroGenics USD 184M 82M 2026-03
Merck USD 317.37B 20.27B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06